You have not verified your Email yet. Please verify your Email to create alerts
Verify EmailJAGSNPHARM
Jagsonpal Pharma
|
Venus Remedies
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
11.8 % | 3.75 % | 26.14 % |
5yr average Equity Multiplier
|
1.31 | 1.64 | 2.82 |
5yr Average Asset Turnover Ratio
|
1.18 | 0.78 | 1.1 |
5yr Avg Net Profit Margin
|
7.67 % | 2.2 % | 9.03 % |
Price to Book
|
5.17 | 0.95 | 7.65 |
P/E
|
35.69 | 15.37 | 35.48 |
5yr Avg Cash Conversion Cycle
|
-6.79 Days | 62.86 Days | -18.02 Days |
Inventory Days
|
60.26 Days | 110.85 Days | 77.22 Days |
Days Receivable
|
25.87 Days | 37.87 Days | 81.36 Days |
Days Payable
|
67.96 Days | 50.32 Days | 175.58 Days |
5yr Average Interest Coverage Ratio
|
51.15 | 42.3 | 10.3 |
5yr Avg ROCE
|
15.71 % | 5.53 % | 33.27 % |
5yr Avg Operating Profit Margin
|
11.17 % | 12.68 % | 17.37 % |
5 yr average Debt to Equity
|
0.03 | 0.38 | 0.73 |
5yr CAGR Net Profit
|
29.92 % | n/a | 29.43 % |
5yr Average Return on Assets
|
9.04 % | 3.42 % | 10.17 % |
Shareholdings
|
|||
Promoter Holding
|
68.09 % | 41.76 % | 72.51 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-2.25 % | 5.87 % | 6.76 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -6.16 % |
Jagsonpal Pharma
|
Venus Remedies
|
Gufic Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|